• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    75 Biggest Movers From Yesterday

    3/22/22 4:42:32 AM ET
    $AA
    $AAMC
    $AKAN
    $ALLR
    Aluminum
    Industrials
    Real Estate
    Finance
    Get the next $AA alert in real time by email

    Gainers

    • NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) gained 58.4% to settle at $1.22. Clarus Therapeutics recently reported initiation of Phase 4 trial of JATENZO for treatment of hypogonadal men with chronic kidney disease.
    • Yumanity Therapeutics, Inc. (NASDAQ:YMTX) shares surged 58% to settle at $1.77.
    • Ipsidy Inc. (NASDAQ:AUID) gained 54.1% to settle at $4.67. authID.ai reported 2021 revenue of $2.3 million, up from $2.1 million year over year.
    • BitNile Holdings, Inc. (NYSE:NILE) gained 48.6% to close at $0.83. BitNile's TurnOnGreen resumed expansion of its electric vehicle charging network and e-commerce operations.
    • United Time Technology Co., Ltd. (NASDAQ:UTME) shares climbed 44.8% to close at $2.78 following a 12% surge on Friday.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) surged 44% to settle at $1.44.
    • Cyren Ltd. (NASDAQ:CYRN) jumped 43.2% to settle at $9.08 following a statement from U.S. President Joe Biden calling for increased cybersecurity measures.
    • PainReform Ltd. (NASDAQ:PRFX) surged 39.6% to close at $1.55. PainReform recently reported a FY21 net loss of $7.2 million.

    Check out our premarket coverage here .

    • BT Brands, Inc. (NASDAQ:BTBD) gained 38.7% to close at $2.15 after dropping 39% on Friday. BT Brands recently posted Q4 sales of $1.85 million.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) jumped 38% to close at $0.4556 after declining more than 22% on Friday.
    • O2Micro International Limited (NASDAQ:OIIM) gained 34.4% to close at $4.34. O2Micro reported the receipt of a preliminary non-binding proposal to acquire the company.
    • Qutoutiao Inc. (NASDAQ:QTT) gained 32.8% to settle at $2.35.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) gained 28.8% to close at $0.2641 after dipping around 32% on Friday.
    • Scopus BioPharma Inc. (NASDAQ:SCPS) rose 28.3% to settle at $0.8205.
    • Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) gained 28.1% to settle at $1.15. The company recently posted a narrower-than-expected quarterly loss.
    • Anaplan, Inc. (NYSE:PLAN) climbed 27.7% to close at $64.60 as the company agreed to be acquired by Thoma Bravo in an all-cash deal valued at around $10.7 billion.
    • Hudson Capital Inc. (NASDAQ:HUSN) shares rose 27.1% to settle at $2.63. Hudson Capital said its Fr8PrivateFleet product secured new and existing customers, including one of Mexico’s largest food producers.
    • Cadiz Inc. (NASDAQ:CDZI) rose 26.8% to close at $2.22 after the company announced a new $12 million equity investment from a registered direct offering of 6.86 million shares of common stock at $1.75 per share.
    • Cenntro Electric Group Limited (NASDAQ:CENN) gained 26.4% to settle at $2.2750.
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) gained 26.2% to settle at $7.56 following a statement from U.S. President Joe Biden calling for increased cybersecurity measures.
    • SuperCom Ltd. (NASDAQ:SPCB) jumped 25.7% to close at $0.6915.
    • Alleghany Corporation (NYSE:Y) gained 24.8% to close at $844.60 after Berkshire Hathaway announced it would acquire the company for $848.02/share.
    • SecureWorks Corp. (NASDAQ:SCWX) surged 24.7% to settle at $13.26. Goldman Sachs and Morgan Stanley lowered their price targets on the stock.
    • Fast Radius, Inc. (NASDAQ:FSRD) gained 24.6% to settle at $1.67. Fast Radius recently named Erin Stone as General Counsel and Corporate Secretary, and James Erkenswick as Chief Accounting Officer.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) rose 23.8% to close at $3.07 after jumping 5% on Friday.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) gained 23.7% to settle at $1.83. Quoin Pharmaceuticals recently announced submission of IND for QRX003 for Netherton Syndrome.
    • IZEA Worldwide, Inc. (NASDAQ:IZEA) jumped 23.6% to close at $1.31.
    • Heliogen, Inc. (NASDAQ:HLGN) gained 22.2% to settle at $6.01.
    • LogicMark, Inc. (NASDAQ:LGMK) climbed 22% to close at $2.88.
    • Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) rose 21.9% to close at $1.56.
    • Intrepid Potash, Inc. (NYSE:IPI) jumped 21.6% to close at $84.04.
    • EuroDry Ltd. (NASDAQ:EDRY) rose 21.2% to settle at $29.59.
    • NEXGEL, Inc. (NASDAQ:NXGL) gained 20.5% to close at $2.06. NexGel (NASDAQ:NXGL) reported $533.00 thousand in sales for the fourth quarter.
    • Zosano Pharma Corporation (NASDAQ:ZSAN) climbed 20.3% to close at $0.2147. Zosano Pharma recently reduced 31% of its staff as the FDA rejected its already-rejected migraine drug last month.
    • Zenvia Inc. (NASDAQ:ZENV) rose 20.2% to settle at $5.71. Zenvia, last week, reported Q4 adjusted gross profit of R$62.1 million.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) gained 19.9% to close at $9.22.
    • OneConnect Financial Technology Co., Ltd. (NYSE:OCFT) jumped 18.4% to close at $1.67.
    • Sera Prognostics, Inc. (NASDAQ:SERA) climbed 17.6% to settle at $3.48.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 17.6% to close at $2.27.
    • Cognyte Software Ltd. (NASDAQ:CGNT) gained 17.1% to close at $12.34. Stifel maintained Cognyte Software with a Buy and lowered the price target from $26 to $21.
    • Akanda Corp. (NASDAQ:AKAN) rose 13.7% to close at $8.41.
    • MarketWise, Inc. (NASDAQ:MKTW) shares rose 12.9% to settle at $5.00. The company recently posted upbeat quarterly sales.
    • Owlet, Inc. (NYSE:OWLT) gained 11.9% to close at $3.58.
    • Jowell Global Ltd. (NASDAQ:JWEL) surged 11.7% to close at $2.38.
    • Century Aluminum Company (NASDAQ:CENX) jumped 11.1% to close at $27.09.
    • Mullen Automotive, Inc. (NASDAQ:MULN) rose 10.7% to close at $3.21 after jumping around 19% on Friday.
    • Alcoa Corporation (NYSE:AA) surged 10% to close at $90.69. Argus Research maintained Alcoa with a Buy and raised the price target from $68 to $95.


    Losers

    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares tumbled 69% to close at $2.31 on Monday after releasing topline results from its Phase 1 SEAL study evaluating ADAIR, an abuse-deterrent formulation of immediate-release (IR) dextroamphetamine for attention deficit hyperactivity disorder (ADHD). The study did not meet its primary endpoint, Emax Drug Liking. ADAIR scored similarly to what was observed in an earlier proof-of-concept study.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) shares dipped 43.2% to close at $0.2750 after the company said it would terminate its URIROX-2 Study to reduce kidney stone disease progression.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) dipped 36.7% to settle at $1.50 after the company announced an upsized public offering of 37.5 million units at $1.60 per unit.
    • Hour Loop, Inc. (NASDAQ:HOUR) dropped 32.8% to close at $3.60.
    • Jewett-Cameron Trading Company Ltd. (NASDAQ:JCTCF) fell 25.6% to settle at $5.76.
    • CinCor Pharma, Inc. (NASDAQ:CINC) dropped 25.1% to close at $14.82.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) fell 24.4% to settle at $7.79.
    • BEST Inc. (NYSE:BEST) fell 24.2% to close at $0.7582 after jumping over 73% on Friday.
    • Connect Biopharma Holdings Limited (NASDAQ:CNTB) fell 23.4% to close at $3.79.
    • Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) dipped 23.4% to close at $5.67.
    • Nuvectis Pharma, Inc. (NASDAQ:NVCT) declined 23% to close at $6.03.
    • Boxed, Inc. (NYSE:BOXD) fell 20.8% to close at $8.04. Boxed recently posted Q4 loss of $1.64 per share.
    • 17 Education & Technology Group Inc. (NASDAQ:YQ) fell 20.6% to close at $3.00.
    • Sonim Technologies, Inc. (NASDAQ:SONM) dipped 20.2% to settle at $1.03. Sonim Technologies posted Q4 sales of $15.9 million.
    • ImmunoGen, Inc. (NASDAQ:IMGN) fell 18.3% to close at $3.79 after the company announced full results from the pivotal SORAYA trial of mirvetuximab soravtansine in ovarian cancer at the SGO annual meeting. Also, RBC Capital downgraded the stock from Outperform to Sector Perform and lowered its price target from $9 to $6.
    • Telesat Corporation (NASDAQ:TSAT) declined 17.9% to close at $18.81. Telesat recently posted FY 2021 adjusted EBITDA of C$603 million.
    • Sutro Biopharma, Inc. (NASDAQ:STRO) fell 17.8% to close at $7.97.
    • Zhihu Inc. (NYSE:ZH) fell 17.7% to close at $2.60 after jumping 55% on Friday.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) fell 16.4% to close at $1.07. TC BioPharm recently said FDA orphan drug status was granted for OmniImmune.
    • EQRx, Inc. (NASDAQ:EQRX) dipped 14.7% to close at $3.54. EQRx is scheduled to hold Q4 financial results conference call on Wednesday, March 23, 2022.
    • KE Holdings Inc. (NYSE:BEKE) fell 14.1% to close at $12.15.
    • Shopify Inc. (NYSE:SHOP) fell 12.4% to close at $683.45, possibly selling off following a rally heading into Friday's close.
    • Altisource Asset Management Corporation (NYSE:AAMC) fell 12% to close at $15.75.
    • Color Star Technology Co., Ltd. (NASDAQ:CSCW) fell 11.2% to close at $0.2366 after gaining 8% on Friday.
    • MOGU Inc. (NYSE:MOGU) shares fell 10.6% to settle at $0.3089 after climbing 23% on Friday.
    • Palisade Bio, Inc. (NASDAQ:PALI) fell 8.5% to settle at $0.8050. Palisade recently reported cash and cash equivalents as of Dec. 31, 2021 of $10.5 million.
    • China Eastern Airlines Corporation Limited (NYSE:CEA) shares fell 6.3% to close at $17.83. A China Eastern Airlines Boeing Co. (NYSE:BA) 737-800NG plane carrying 132 people crashed in China’s southwestern province of Guangxi, reported Bloomberg.
    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $AAMC
    $AKAN
    $ALLR

    CompanyDatePrice TargetRatingAnalyst
    KE Holdings Inc
    $BEKE
    2/3/2026$19.00Buy → Neutral
    Goldman
    CADIZ Inc.
    $CDZI
    2/2/2026$10.00Buy
    Maxim Group
    Shopify Inc.
    $SHOP
    2/2/2026Neutral → Buy
    Arete
    Alcoa Corporation
    $AA
    1/27/2026$64.00Overweight → Equal-Weight
    Morgan Stanley
    Sutro Biopharma Inc.
    $STRO
    1/20/2026$23.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Boeing Company
    $BA
    1/15/2026$277.00 → $298.00Outperform
    Bernstein
    Alcoa Corporation
    $AA
    1/13/2026$71.00Overweight → Equal Weight
    Wells Fargo
    Palisade Bio Inc.
    $PALI
    1/9/2026$7.00Buy
    B. Riley Securities
    More analyst ratings

    $AA
    $AAMC
    $AKAN
    $ALLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lulus Appoints Heidi Crane as Permanent Chief Financial Officer

    CHICO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. ("Lulus" or the "Company") (NASDAQ:LVLU) today announced the appointment of Heidi Crane as its permanent Chief Financial Officer ("CFO"), effective February 4, 2026. Ms. Crane previously served as the Company's fractional CFO since October 13, 2025. "We're thrilled to have Heidi officially join our team as permanent CFO," said Crystal Landsem, CEO of Lulus. "After working closely with us in a fractional capacity, Heidi has demonstrated exceptional financial discipline, strategic insight, and a deep understanding of our business. Heidi's transition to Lulus' permanent CFO was a natural next step, and we'r

    2/5/26 4:03:00 PM ET
    $LVLU
    Catalog/Specialty Distribution
    Consumer Discretionary

    Century Aluminum Sets Date for Fourth Quarter 2025 Earnings Announcement

    CHICAGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) will report fourth quarter 2025 earnings on Thursday, February 19, 2026, after market close. The news release will be issued through GlobeNewswire. The company will hold a follow-up conference call on Thursday, February 19, 2026, at 5:00 p.m. Eastern time. The earnings call will be webcast live on the Century Aluminum Company website, located at www.centuryaluminum.com. Plan to begin the registration process at least 10 minutes before the live call is scheduled to begin. A replay of the webcast will be archived and available for replay approximately two hours following the live call. Contact: Investors: Ch

    2/5/26 11:49:13 AM ET
    $CENX
    Aluminum
    Industrials

    Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

    Virtual presentation scheduled for Thursday, February 26th at 12:40 PM ET Access the webcast here Carlsbad, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced that JD Finley, Chief Executive Officer, and Dr. Mitchell Jones, President and Chief Medical Officer, will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, being held in a virtual format February 25–26, 2026. The Company's virtual presentation is scheduled for Thur

    2/5/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AA
    $AAMC
    $AKAN
    $ALLR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 26, 2024 - FDA Roundup: March 26, 2024

    For Immediate Release: March 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA proposed a ban of electrical stimulation devices intended to reduce or stop self-injurious or aggressive behavior, a step rarely taken by the agency. The agency has determined that these devices present an unreasonable and substantial risk of

    3/26/24 3:38:14 PM ET
    $IMGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ELAHERE issued to IMMUNOGEN INC

    Submission status for IMMUNOGEN INC's drug ELAHERE (SUPPL-5) with active ingredient MIRVETUXIMAB SORAVTANSINE-GYNX has changed to 'Approval' on 03/22/2024. Application Category: BLA, Application Number: 761310, Application Classification:

    3/22/24 1:48:21 PM ET
    $IMGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ELAHERE issued to IMMUNOGEN INC

    Submission status for IMMUNOGEN INC's drug ELAHERE (ORIG-1) with active ingredient MIRVETUXIMAB SORAVTANSINE-GYNX has changed to 'Approval' on 11/14/2022. Application Category: BLA, Application Number: 761310, Application Classification:

    11/15/22 5:01:07 PM ET
    $IMGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $AAMC
    $AKAN
    $ALLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Lawlor Sally Bridget

    4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)

    2/6/26 5:24:03 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Director Cooper Joseph Patrick

    4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)

    2/6/26 5:21:52 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Director Culverwell Anthony James

    4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)

    2/6/26 5:20:19 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    $AA
    $AAMC
    $AKAN
    $ALLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KE Holdings downgraded by Goldman with a new price target

    Goldman downgraded KE Holdings from Buy to Neutral and set a new price target of $19.00

    2/3/26 6:53:05 AM ET
    $BEKE
    Real Estate
    Finance

    Maxim Group initiated coverage on Cadiz with a new price target

    Maxim Group initiated coverage of Cadiz with a rating of Buy and set a new price target of $10.00

    2/2/26 7:47:52 AM ET
    $CDZI
    Water Supply
    Utilities

    Shopify upgraded by Arete

    Arete upgraded Shopify from Neutral to Buy

    2/2/26 6:47:59 AM ET
    $SHOP
    Computer Software: Prepackaged Software
    Technology

    $AA
    $AAMC
    $AKAN
    $ALLR
    SEC Filings

    View All

    SEC Form 6-K filed by KE Holdings Inc

    6-K - KE Holdings Inc. (0001809587) (Filer)

    2/6/26 6:01:43 AM ET
    $BEKE
    Real Estate
    Finance

    Owlet Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Owlet, Inc. (0001816708) (Filer)

    2/5/26 5:25:05 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    SEC Form 144 filed by Shopify Inc.

    144 - SHOPIFY INC. (0001594805) (Subject)

    2/5/26 4:28:55 PM ET
    $SHOP
    Computer Software: Prepackaged Software
    Technology

    $AA
    $AAMC
    $AKAN
    $ALLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/21/26 4:05:24 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Williams Donald Allen bought $9,400 worth of shares (5,000 units at $1.88), increasing direct ownership by 687% to 5,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/13/26 9:43:07 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AA
    $AAMC
    $AKAN
    $ALLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NeuroSense Therapeutics Ltd.

    SC 13G - NeuroSense Therapeutics Ltd. (0001875091) (Subject)

    12/9/24 4:00:18 PM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by CADIZ Inc.

    SC 13G/A - CADIZ INC (0000727273) (Subject)

    12/6/24 6:52:25 PM ET
    $CDZI
    Water Supply
    Utilities

    Amendment: SEC Form SC 13G/A filed by SecureWorks Corp.

    SC 13G/A - SecureWorks Corp (0001468666) (Subject)

    12/6/24 3:33:53 PM ET
    $SCWX
    Computer Software: Prepackaged Software
    Technology

    $AA
    $AAMC
    $AKAN
    $ALLR
    Financials

    Live finance-specific insights

    View All

    Century Aluminum Sets Date for Fourth Quarter 2025 Earnings Announcement

    CHICAGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) will report fourth quarter 2025 earnings on Thursday, February 19, 2026, after market close. The news release will be issued through GlobeNewswire. The company will hold a follow-up conference call on Thursday, February 19, 2026, at 5:00 p.m. Eastern time. The earnings call will be webcast live on the Century Aluminum Company website, located at www.centuryaluminum.com. Plan to begin the registration process at least 10 minutes before the live call is scheduled to begin. A replay of the webcast will be archived and available for replay approximately two hours following the live call. Contact: Investors: Ch

    2/5/26 11:49:13 AM ET
    $CENX
    Aluminum
    Industrials

    Shopify to Announce Fourth-Quarter and Full-Year 2025 Financial Results February 11, 2026

    Internet, Everywhere--(Newsfile Corp. - January 28, 2026) - Shopify Inc. ((NASDAQ, TSX:SHOP) plans to announce financial results for the quarter and year ended December 31, 2025, before markets open on Wednesday, February 11, 2026. Shopify's management team will host a conference call to discuss fourth-quarter and full-year results at 8:30 a.m. ET on Wednesday, February 11, 2026. The conference call will be available via webcast on the investor relations section of Shopify's website at https://shopifyinvestors.com/news-and-events. An archived replay of the webcast will be available following the conclusion of the call.About ShopifyShopify provides essential internet infrastructure for commer

    1/28/26 7:00:00 AM ET
    $SHOP
    Computer Software: Prepackaged Software
    Technology

    Boeing Reports Fourth Quarter Results

    ARLINGTON, Va., Jan. 27, 2026 /PRNewswire/ -- Fourth Quarter 2025 Acquired Spirit AeroSystems in December underscoring commitment to safety, quality, and production stabilityRevenue increased to $23.9 billion primarily reflecting 160 commercial deliveriesEarnings reflects $9.6 billion gain on sale associated with closing the Digital Aviation Solutions transaction Operating cash flow of $1.3 billion and free cash flow (non-GAAP)* of $0.4 billionFull Year 2025 Revenue of $89.5 billion and 600 commercial deliveries reflect the highest annual totals since 2018Total company backlog grew to a record $682 billion, including over 6,100 commercial airplanesTable 1. Summary Financial Results Fourth Q

    1/27/26 7:30:00 AM ET
    $BA
    Aerospace
    Industrials

    $AA
    $AAMC
    $AKAN
    $ALLR
    Leadership Updates

    Live Leadership Updates

    View All

    Lulus Appoints Heidi Crane as Permanent Chief Financial Officer

    CHICO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. ("Lulus" or the "Company") (NASDAQ:LVLU) today announced the appointment of Heidi Crane as its permanent Chief Financial Officer ("CFO"), effective February 4, 2026. Ms. Crane previously served as the Company's fractional CFO since October 13, 2025. "We're thrilled to have Heidi officially join our team as permanent CFO," said Crystal Landsem, CEO of Lulus. "After working closely with us in a fractional capacity, Heidi has demonstrated exceptional financial discipline, strategic insight, and a deep understanding of our business. Heidi's transition to Lulus' permanent CFO was a natural next step, and we'r

    2/5/26 4:03:00 PM ET
    $LVLU
    Catalog/Specialty Distribution
    Consumer Discretionary

    Dave O'Hara Joins Cadiz Board of Directors

    Former Microsoft Commercial CFO brings decades of experience in corporate finance and commercial strategy LOS ANGELES, Feb. 4, 2026 /PRNewswire/ -- Cadiz, Inc. (NASDAQ:CDZI, the ", Company", )) announced today that Mr. Dave O'Hara, a senior finance executive with extensive experience in corporate finance, commercial strategy and large-scale growth initiatives, has joined the Company's Board of Directors. Mr. O'Hara spent more than 20 years at Microsoft in senior executive leadership roles, most recently serving as Executive Vice President and Chief Financial Officer of Microso

    2/4/26 9:46:00 AM ET
    $CDZI
    Water Supply
    Utilities

    Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

    Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's disease, and late-stage clinical trial design Appointments strengthen Palisade Bio's clinical strategy as PALI-2108 advances toward Phase 2 development in ulcerative colitis and fibrostenotic Crohn's disease, with a Phase 2 UC IND submission planned for the first half of 2026 Carlsbad, CA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today an

    1/29/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care